228 related articles for article (PubMed ID: 30582694)
21. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
23. Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification.
Bockman MR; Engelhart CA; Dawadi S; Larson P; Tiwari D; Ferguson DM; Schnappinger D; Aldrich CC
ACS Infect Dis; 2018 Jul; 4(7):1102-1113. PubMed ID: 29663798
[TBL] [Abstract][Full Text] [Related]
24. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.
Somu RV; Boshoff H; Qiao C; Bennett EM; Barry CE; Aldrich CC
J Med Chem; 2006 Jan; 49(1):31-4. PubMed ID: 16392788
[TBL] [Abstract][Full Text] [Related]
25. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
26. Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis.
Dawadi S; Boshoff HIM; Park SW; Schnappinger D; Aldrich CC
ACS Med Chem Lett; 2018 Apr; 9(4):386-391. PubMed ID: 29670706
[TBL] [Abstract][Full Text] [Related]
27. Iron Acquisition Pathways as Targets for Antitubercular Drugs.
Meneghetti F; Villa S; Gelain A; Barlocco D; Chiarelli LR; Pasca MR; Costantino L
Curr Med Chem; 2016; 23(35):4009-4026. PubMed ID: 27281295
[TBL] [Abstract][Full Text] [Related]
28. Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis.
Vergnolle O; Xu H; Tufariello JM; Favrot L; Malek AA; Jacobs WR; Blanchard JS
J Biol Chem; 2016 Oct; 291(42):22315-22326. PubMed ID: 27566542
[TBL] [Abstract][Full Text] [Related]
29. Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study.
Tawari NR; Degani MS
Mol Divers; 2011 May; 15(2):435-44. PubMed ID: 20306296
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin.
Quadri LE; Sello J; Keating TA; Weinreb PH; Walsh CT
Chem Biol; 1998 Nov; 5(11):631-45. PubMed ID: 9831524
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
[TBL] [Abstract][Full Text] [Related]
33. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
34. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of aryl acid adenylation domains involved in bacterial siderophore synthesis.
Miethke M; Bisseret P; Beckering CL; Vignard D; Eustache J; Marahiel MA
FEBS J; 2006 Jan; 273(2):409-19. PubMed ID: 16403027
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
Mutai P; Pavadai E; Wiid I; Ngwane A; Baker B; Chibale K
Bioorg Med Chem Lett; 2015 Jun; 25(12):2510-3. PubMed ID: 25977095
[TBL] [Abstract][Full Text] [Related]
37. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
38. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.
Ferreras JA; Ryu JS; Di Lello F; Tan DS; Quadri LE
Nat Chem Biol; 2005 Jun; 1(1):29-32. PubMed ID: 16407990
[TBL] [Abstract][Full Text] [Related]
39. Ethambutol analogues as potential antimycobacterial agents.
Häusler H; Kawakami RP; Mlaker E; Severn WB; Stütz AE
Bioorg Med Chem Lett; 2001 Jul; 11(13):1679-81. PubMed ID: 11425536
[TBL] [Abstract][Full Text] [Related]
40. In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors.
Rakshit G; Biswas A; Jayaprakash V
Pathogens; 2023 Dec; 12(12):. PubMed ID: 38133316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
